Genetic variant offers protection against TB and leprosy
A study into why some people are more resistant than others to diseases such as tuberculosis and leprosy has identified a new genetic variant which affects susceptibility to…
Search results
Showing 1 to 20 results of 481
New malaria maps to guide battle against the disease
A new suite of malaria maps has revealed the current global pattern of the disease in unprecedented detail, allowing researchers to see how malaria has changed over several…
When will the world be vaccinated against Covid-19?
How should the global community prioritise the distribution of Covid-19 vaccines to give us the best chance of ending the pandemic and saving lives? Could booster…
G7 progress against pandemic threats is promising – now they must act
After many global conversations about lessons we can learn from the Covid-19 crisis, the G7 summit in Germany showed increasing commitment to facing threats of disease…
- Author
Lisa Heinrich
Protecting the lungs against 'collateral damage' from the immune system
A study published today in the journal ‘Science’ shows how our bodies try to minimise potential ‘collateral damage’ caused by our immune system when fighting infection. The…
Landmark moment in the fight against Ebola: what have we learnt?
The licensing of the first Ebola vaccine is a great achievement for the global healthcare community. What made it possible, and what lessons can we use to prevent and control…
- Author
Charlie Weller
One in ten women in Britain report having experienced sex against their will
One in ten women (9.8%) and roughly one in seventy men (1.4%), when asked “Has anyone actually made you have sex with them, against your will?”, said yes, according to new…
Exposure to worm infection in the womb may protect against eczema, study suggests
Exposure to worm infections in the womb may protect a newborn infant from developing eczema, a study funded by the Wellcome Trust suggests. A large trial in Uganda showed…
How well do first and second vaccine doses work against Covid-19?
Critics warned against the UK policy of leaving a longer gap between doses of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines. Now we have more data, what…
‘You can never do something for us without us’: Why community-led research is vital in the fight against AMR
In South Africa, antimicrobial resistance (AMR) kills thousands of people every year. These Wellcome-funded research teams are working with local communities to better…
- Author
Jane Bracher
A new way of developing vaccines for Covid-19 could help the world to prepare for future outbreaks
A vaccine for Covid-19 which uses cutting-edge RNA technology has entered phase 1 clinical trials. If successful, it could revolutionise the future of vaccine development.
- Author
- Charlie Weller
Two-pronged immune response offers hope for effective Salmonella vaccine
Research from Malawi, Birmingham and Liverpool has renewed hope that an effective vaccine could be developed against nontyphoidal strains of Salmonella.
UK public overwhelmingly support equitable global access to COVID-19 vaccines and treatments
A YouGov poll, commissioned by Wellcome, reveals that 9 in 10 people (90%) in the UK say COVID-19 treatments and vaccines should first be provided for those who need them…
German public overwhelmingly support equitable global access to COVID-19 vaccines and treatments
Ensuring the people who most need access to vaccines and effective treatments against Covid-19, wherever they are in the world, is supported by almost 9 in 10 German adults.
Wellcome responds to progress on antimicrobial resistance
Jeremy Knox, Wellcome's Head of Policy, Infectious Disease, comments on the progress made in the fight against antimicrobial resistance at the 4th Global High-Level…
Ebola vaccine shows promising results
Interim results from the Guinean phase III trial of the Ebola vaccine known as VSV-EBOV, co-funded by the Wellcome Trust, indicate that it is highly effective against the…
US public overwhelmingly support equitable global access to COVID-19 vaccines and treatments
US public overwhelmingly support equitable global access to COVID-19 vaccines and treatments.
Pneumococcal vaccine offers protection to HIV-infected African adults in clinical trial
A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults…
How France is persuading its citizens to get vaccinated
One in three French people think vaccines are unsafe, but across the country vaccine coverage is rising. Alex Whiting looks at how France is fighting back against vaccine…
- Author
Alex Whiting